NASDAQ:WMGI - Wright Medical Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$29.98
+0.30 (1.20%)
Get New Wright Medical Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WMGI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WMGI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Wright Medical Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $29.98.

This chart shows the closing price for WMGI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Wright Medical Group. This rating has held steady since July 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 11 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 10 hold ratings
  • 0 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/26/2020Stifel NicolausDowngradeBuy ➝ Hold$30.00Low
7/29/2020Needham & Company LLCReiterated RatingHoldLow
3/13/2020Needham & Company LLCDowngradeBuy ➝ HoldLow
12/23/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$30.75N/A
12/6/2019Wells Fargo & CompanyReiterated RatingHoldLow
11/27/2019SVB LeerinkDowngradeOutperform ➝ Market PerformLow
11/18/2019SVB LeerinkDowngradeOutperform ➝ Market PerformLow
11/15/2019Needham & Company LLCLower Price TargetBuy$32.00 ➝ $30.75Low
11/12/2019Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
11/12/2019Northcoast ResearchDowngradeBuy ➝ NeutralLow
11/11/2019Wells Fargo & CompanyReiterated RatingHoldLow
11/11/2019Robert W. BairdDowngradeOutperform ➝ Neutral$28.00 ➝ $31.00Low
11/4/2019Cantor FitzgeraldDowngradeOverweight ➝ NeutralMedium
11/4/2019Piper Jaffray CompaniesDowngradeOverweight ➝ NeutralHigh
8/16/2019Piper Jaffray CompaniesSet Price TargetBuy$27.00Low
8/12/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$28.00 ➝ $23.00Medium
8/9/2019Bank of AmericaDowngradeBuy ➝ Neutral$25.00Low
8/8/2019OppenheimerLower Price TargetOutperform$34.00 ➝ $29.00Medium
8/8/2019Credit Suisse GroupLower Price TargetOutperform$34.00 ➝ $30.00Low
8/8/2019BMO Capital MarketsLower Price TargetOutperform$36.00 ➝ $30.00High
8/8/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$34.00 ➝ $24.00High
7/23/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$38.00 ➝ $33.00Low
5/8/2019OppenheimerSet Price TargetHold$34.00Medium
4/10/2019Needham & Company LLCReiterated RatingBuy$38.00Low
3/14/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$33.00 ➝ $36.00Medium
3/11/2019Wells Fargo & CompanyReiterated RatingBuyMedium
2/27/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$33.00 ➝ $34.00High
2/27/2019Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$35.00 ➝ $39.00High
2/27/2019Jefferies Financial GroupBoost Price TargetBuy$40.00Medium
2/27/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$35.00 ➝ $38.00High
1/14/2019Cantor FitzgeraldSet Price TargetBuy$35.00Medium
1/7/2019Needham & Company LLCReiterated RatingBuy$35.00High
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$33.00Low
12/10/2018Cantor FitzgeraldReiterated RatingBuy$35.00Medium
11/28/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$31.00Low
11/8/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$32.00 ➝ $35.00Medium
11/8/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$31.00 ➝ $35.00Medium
11/8/2018Piper Jaffray CompaniesBoost Price TargetOverweight$35.00Medium
11/8/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$30.00 ➝ $32.00Medium
11/8/2018OppenheimerSet Price TargetHold$30.00N/A
10/25/2018Needham & Company LLCBoost Price TargetBuy$30.00 ➝ $35.00High
8/29/2018BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$28.00 ➝ $31.00Medium
8/28/2018Needham & Company LLCUpgradeHold ➝ Buy$30.00High
8/21/2018Stifel NicolausInitiated CoverageBuy$34.00High
8/9/2018Piper Jaffray CompaniesBoost Price TargetOverweight$32.00High
8/9/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $32.00High
8/9/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$28.00 ➝ $30.00High
8/9/2018Bank of AmericaUpgradeNeutral ➝ Buy$28.00 ➝ $34.00Low
8/9/2018OppenheimerSet Price TargetHold$28.00High
8/9/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$30.00 ➝ $35.00High
7/10/2018BMO Capital MarketsReiterated RatingOutperform ➝ Market Perform$25.00 ➝ $25.00Low
6/21/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$27.00 ➝ $32.00High
6/13/2018GuggenheimUpgradeNeutral ➝ BuyHigh
5/10/2018OppenheimerSet Price TargetHold$25.00High
2/28/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$28.00 ➝ $25.00High
2/28/2018BarclaysReiterated RatingOverweight ➝ Overweight$27.00 ➝ $25.00Low
2/28/2018OppenheimerSet Price TargetHold$25.00High
1/8/2018Cantor FitzgeraldSet Price TargetBuy$30.00Medium
1/5/2018Cantor FitzgeraldReiterated RatingOverweight ➝ OverweightHigh
11/3/2017Jefferies Financial GroupReiterated RatingBuyN/A
11/2/2017Royal Bank of CanadaReiterated RatingBuy$30.00N/A
11/2/2017BarclaysLower Price TargetOverweight$33.00 ➝ $30.00N/A
11/2/2017BMO Capital MarketsLower Price TargetOutperform$34.00 ➝ $31.00N/A
11/2/2017Needham & Company LLCReiterated RatingHoldN/A
10/12/2017Jefferies Financial GroupReiterated RatingBuy$33.00N/A
10/6/2017Robert W. BairdReiterated RatingBuy$33.00N/A
10/3/2017Royal Bank of CanadaReiterated RatingBuy$31.00Low
9/1/2017Needham & Company LLCReiterated RatingHoldLow
8/4/2017Jefferies Financial GroupReiterated RatingBuy$33.00High
8/3/2017Piper Jaffray CompaniesReiterated RatingBuy$34.00High
8/3/2017OppenheimerSet Price TargetHold$29.00 ➝ $30.00High
6/29/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$33.00Medium
5/4/2017OppenheimerSet Price TargetHold$29.00Low
5/4/2017Jefferies Financial GroupBoost Price TargetBuy$30.00 ➝ $33.00Medium
5/4/2017BMO Capital MarketsReiterated RatingBuy$34.00High
5/4/2017Needham & Company LLCReiterated RatingHoldHigh
4/24/2017Jefferies Financial GroupReiterated RatingBuyLow
4/11/2017Bank of AmericaDowngradeBuy ➝ NeutralHigh
3/21/2017Northcoast ResearchUpgradeNeutral ➝ Buy$36.00Medium
2/22/2017Needham & Company LLCReiterated RatingHoldN/A
2/22/2017Jefferies Financial GroupReiterated RatingBuy$30.00N/A
2/22/2017BMO Capital MarketsBoost Price TargetBuy$31.00N/A
2/15/2017Needham & Company LLCDowngradeBuy ➝ HoldN/A
1/3/2017GuggenheimDowngradeBuy ➝ NeutralN/A
(Data available from 11/28/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/1/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/1/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/31/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/29/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/28/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Wright Medical Group logo
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Read More

Today's Range

Now: $29.98
Low: $29.98
High: $29.98

50 Day Range

MA: $30.23
Low: $29.98
High: $30.72

52 Week Range

Now: $29.98
Low: $23.14
High: $30.74

Volume

9,689 shs

Average Volume

2,015,203 shs

Market Capitalization

$3.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Wright Medical Group?

The following Wall Street sell-side analysts have issued stock ratings on Wright Medical Group in the last twelve months:
View the latest analyst ratings for WMGI.

What is the current price target for Wright Medical Group?

0 Wall Street analysts have set twelve-month price targets for Wright Medical Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Wright Medical Group in the next year.
View the latest price targets for WMGI.

What is the current consensus analyst rating for Wright Medical Group?

Wright Medical Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for WMGI.

What other companies compete with Wright Medical Group?

How do I contact Wright Medical Group's investor relations team?

Wright Medical Group's physical mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 38117. The medical device company's listed phone number is 31-20-521-4777 and its investor relations email address is [email protected] The official website for Wright Medical Group is www.wright.com.